175 related articles for article (PubMed ID: 17547524)
1. Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up?
Linkov F; Yurkovetsky Z; Lokshin A
Future Oncol; 2007 Jun; 3(3):295-8. PubMed ID: 17547524
[TBL] [Abstract][Full Text] [Related]
2. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
Ambeba E; Linkov F
Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer screening and biomarkers.
Brooks M
Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
[TBL] [Abstract][Full Text] [Related]
4. The case for early detection.
Etzioni R; Urban N; Ramsey S; McIntosh M; Schwartz S; Reid B; Radich J; Anderson G; Hartwell L
Nat Rev Cancer; 2003 Apr; 3(4):243-52. PubMed ID: 12671663
[TBL] [Abstract][Full Text] [Related]
5. Proteomic approaches in lung cancer biomarker development.
Cho JY; Sung HJ
Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
[TBL] [Abstract][Full Text] [Related]
6. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
Draghici S; Chatterjee M; Tainsky MA
Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
[TBL] [Abstract][Full Text] [Related]
7. Discovery and application of protein biomarkers for ovarian cancer.
Gagnon A; Ye B
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
[TBL] [Abstract][Full Text] [Related]
9. Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.
Ebert MP; Korc M; Malfertheiner P; Röcken C
J Proteome Res; 2006 Jan; 5(1):19-25. PubMed ID: 16396491
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for prostate cancer detection.
Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies.
de Vries AC; Kuipers EJ
Helicobacter; 2007 Nov; 12 Suppl 2():22-31. PubMed ID: 17991173
[TBL] [Abstract][Full Text] [Related]
12. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
13. New circulating biomarkers for prostate cancer.
Bensalah K; Lotan Y; Karam JA; Shariat SF
Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
[TBL] [Abstract][Full Text] [Related]
14. [NMR research on blood plasma for tumor detection--a method for mass screening?].
Fritzsche H; Sprinz H; Jahn H; Jorke D
Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
[TBL] [Abstract][Full Text] [Related]
15. [Biomarker screening for early detection of cancer].
Wiedemann GJ
Dtsch Med Wochenschr; 2013 Jan; 138(1-2):43-5. PubMed ID: 23250696
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
17. Future of early detection of lung cancer: the role of mouse models.
Shaw AT; Kirsch DG; Jacks T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4999s-5003s. PubMed ID: 16000603
[TBL] [Abstract][Full Text] [Related]
18. Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam.
Roobol MJ; Grenabo A; Schröder FH; Hugosson J
J Natl Cancer Inst; 2007 Sep; 99(17):1296-303. PubMed ID: 17728218
[TBL] [Abstract][Full Text] [Related]
19. Proteomic approaches for serum biomarker discovery in cancer.
Maurya P; Meleady P; Dowling P; Clynes M
Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
[TBL] [Abstract][Full Text] [Related]
20. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]